







































Neonatal complete Freund’s adjuvant-induced
inflammation does not induce or alter hyperalgesic
priming or alter adult distributions of C-fibre dorsal
horn innervation
Andrew H. Coopera,*, Jenna M. Hanmera, Victoria Chapmana,b, Gareth J. Hathwaya
Abstract
Introduction: Inflammation during the neonatal period can exacerbate pain severity following reinjury in adulthood. This is driven by
alterations in the postnatal development of spinal and supraspinal nociceptive circuitry. However, the contribution of alterations in
peripheral nociceptor function remains underexplored.
Objectives: We examined whether neonatal complete Freund’s adjuvant (CFA)-induced inflammation induced or altered adult
development of hyperalgesic priming (inflammation-induced plasticity in nonpeptidergic C fibres) or altered postnatal reorganization
of calcitonin gene-related peptide (CGRP)-expressing and isolectin B4 (IB4)-binding C fibres in the spinal dorsal horn (DH).
Methods:After intraplantar injection of CFA at postnatal day (P) 1, we assessedmechanical thresholds in adult (P60) rats before and
after intraplantar carrageenan. One week later, intraplantar PGE2-induced hypersensitivity persisting for 4 hours was deemed
indicative of hyperalgesic priming. CGRP expression and IB4 binding were examined in adult rat DH after CFA.
Results:P1CFA did not alter baseline adult mechanical thresholds, nor did it change the extent or duration of carrageenan-induced
hypersensitivity. However, this was slower to resolve in female than in male rats. Rats that previously received carrageenan but not
saline were primed, but P1 hind paw CFA did not induce or alter hyperalgesic priming responses to PGE2. In addition, CFA on P1 or
P10 did not alter intensity or patterns of CGRP or IB4 staining in the adult DH.
Conclusion: Complete Freund’s adjuvant-induced inflammation during a critical period of vulnerability to injury during early
postnatal development does not induce or exacerbate hyperalgesic priming or alter the broad distribution of CGRP-expressing or
IB4-binding afferent terminals in the adult dorsal horn.
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1. Introduction
Nociceptive pathways undergo substantial structural and func-
tional postnatal maturation.19 Tissue damage and accompanying
pain during the neonatal period has profound effects on the
development of somatosensory processing with lasting impact on
sensory thresholds and pain perception.5,21,53 Neonates who
undergo surgery or treatment within a neonatal intensive care unit
experience significant painful stimuli, and follow-up studies have
revealed decreased sensitivity to thermal23,50 and mechanical50
stimuli in these patients in later life, as well as increased perception
of high intensity or repeat noxious stimuli and increased analgesic
requirements during subsequent surgeries.23,53
A growing body of preclinical evidence has begun to uncover
mechanisms underpinning altered somatosensory processing after
neonatal inflammatory injury during a critical period of the first 7
postnatal days in rodents. This has revealed alterations in spinal and
supraspinal nociceptive processing that do not occur after similar
injuries later in life.6,30,53,54,57 The consequences of inflammation
during the neonatal periodonprimary afferent fibres (PAFs) in adult life
are less clear. Early work claimed that hind paw inflammation in
neonatal rodents causes a rostrocaudal expansion of sciatic and
saphenous nerve terminal fields in lamina II into adulthood48;
however, this was found to be transient and followed the timecourse
of inflammation.55 Other studies examining visceral afferents have
shown that early-life colonic inflammation increases TRPA114 and
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Nav1.8 expression and decreases A-type K
1 currents,43,44 contrib-
uting to visceral hypersensitivity in adult life. It remains to be
determined whether alterations in the function or central synaptic
connections of PAFs after cutaneous neonatal injury contribute to
increased responses to reinjury in adult life.
Hyperalgesic priming is a model of the transition from acute to
chronic pain in adult life, and is driven by neuronal plasticity in
nonpeptidergic, isolectin B4-positive (IB41) PAF nociceptors
after acute carrageenan or complete Freund’s adjuvant (CFA)-
induced inflammation or neuropathic injury.2,25,40,41,45 This
results in increased duration and extent of mechanical hyper-
sensitivity upon reinjury, mediated by protein kinase Ce signaling,
which occurs in addition to the cAMP-mediated protein kinase A
activity within PAFs that contributes to hypersensitivity during the
initial injury.1,2,41,45 We hypothesized that acute inflammation in
the neonatal period may induce hyperalgesic priming in adult-
hood. To test this, we induced inflammation in neonatal rats with
CFA and then subsequently examined the development of
hyperalgesic priming once rats reached adulthood. We also
examined whether neonatal inflammation altered broad distribu-
tions of peptidergic and nonpeptidergic PAF termination in the
adult superficial dorsal horn (DH).
2. Materials and methods
2.1. Experimental animals
Experimental procedureswere conducted in accordancewith UK
Home Office regulations and followed International Association
for the Study of Pain guidelines. Ethical approval was granted by
the University of Nottingham Animal Welfare and Ethical Review
Board. Time-mated pregnant female Sprague-Dawley rats were
purchased from Charles River UK 1 week before parturition.
Litters (female and male, litter sizes 9–16 animals) were housed
with their dams and animals aged postnatal day (P) 21 or greater
were housed in same-sex groups of 2 to 4 animals in individually
ventilated cages at constant ambient temperature (216 2˚C) and
humidity (50%), with access to food andwater ad libitum. Animals
were maintained on a 12-hour light/dark cycle, and all experi-
mental procedures were performed during their light cycle.
Handling andmaternal separation of pupswas kept to aminimum
and litters were weaned at P21.
2.2. Induction of models of inflammatory injury
Inflammationwas induced in neonatal rats through an intraplantar
injection of complete Freund’s adjuvant (CFA; diluted 1:1 with
0.9% saline; Sigma-Aldrich, United Kingdom). A dose of 10 mL
was selected as higher doses (25 mL) have been previously
shown to cause profound changes in plantar hind paw skin
including infiltration by lymphocytes and mast cells for as long as
8 weeks after neonatal inflammation.55
Neonatal rats were randomly assigned in either control or
treatment groups and then briefly anaesthetised using 4%
isoflurane carried by a mixture of 66% N2O and 33% O2, whilst
placed on a heated mat to preserve body temperature. Using a
27G needle, 10 mL of CFA or saline (control group) was injected
subcutaneously into the centre of the plantar surface of the left
hind paw.
Once adult (P60), the same cohort of rats were then briefly
anaesthetised using 3% isoflurane and received a subcutaneous
injection of 5mL 1%l-carrageenan (Sigma-Aldrich) in 0.9%saline or
0.9% saline in the centre of the left plantar hind paw between the 2
prominent distal tori. Aweek later, animalswere anaesthetised in the
same manner and received an intraplantar injection of 1 mg
prostaglandin E2 (PGE2) in 5 mL saline or 0.9% saline in the same
location. Doses and group sizes were selected based on previous
studies examining hyperalgesic priming.2,9
2.3. Behavioural testing (von Frey test)
Mechanical paw withdrawal thresholds were assessed by
applying von Frey hairs to the plantar surface of the hind paw
for 3 seconds, quantified using a modified up-down method.12
Before baseline measurements, animals were habituated to
testing apparatus (elevated Perspex boxes with a fine steel mesh
floor; Medical Engineering Unit, University of Nottingham) and
hind paw stimulation for 30 minutes on at least 2 occasions. The
experimenter was blinded to treatment groups during all testing.
2.4. Immunohistochemistry
After intraplantar injections of CFA or saline at P1 or P10, adult
(P67) rats were terminally anaesthetised with sodium pentobar-
bital and transcardially perfused with phosphate-buffered saline
(PBS) followed by 4% paraformaldehyde (PFA; Sigma Aldrich).
Lumbar spinal cord segments were collected, postfixed overnight
in 4% PFA, and then cryopreserved in 30% sucrose for 24 h.
Lumbar spinal cords were sectioned at 30 mm on a freezing
microtome (SM201R, Leica, Germany) and immunohistochem-
istry performed on 8 randomly selected, nonadjacent, L4 or 5
transverse sections.
Free-floating sections were washed, then incubated with
blocking solution (3% (vol/vol) goat serum in 0.1 M PBS/0.01%
(vol/vol) Triton X-100) for 2 hours at room temperature followed by
incubation with rabbit anti-calcitonin gene-related peptide
(CGRP; AB15360, Millipore, United Kingdom; 1:1000) and
FITC-conjugated isolectin B4 (IB4; Sigma Aldrich L2895; 1:500)
overnight at room temperature and then with Alexa Fluor 568-
conjugated goat anti-rabbit antibody (A11011, Invitrogen, United
Kingdom; 1:500) for 2 hours at room temperature. Sections were
mounted on gelatinised slides, allowed to dry overnight, and then
coverslipped using Fluoromount-G mounting media (Fisher
Scientific, United Kingdom).
2.5. Microscopy and image quantification
Images of the entire DH ipsilateral to early-life intraplantar
injections were captured with a Leica DMIRE2 inverted epifluor-
escence microscope and a 10X objective (0.25 NA) fitted with a
Hamamatsu OrcaER camera, controlled using Volocity 6.3
software (PerkinElmer). All images were captured using the same
exposure time for each channel (0.5–0.8 seconds). ImageJ/Fiji49
was used to quantify staining and adjust image brightness/
contrast for presentation. Imageswere processed identically, and
the same contrast enhancement was applied to each image.
Imageswere flat-field corrected (per pixel, image/flat-field) against
an imagecapturedof ablank sectionof slidewith the sameexposure
settings. CGRP and IB4 staining were then quantified by placing a
grid 2003300mm,with the 200-mmaxis aligned to the dorsal edge
of the gray matter, at the centre of the DH, consisting of 9 horizontal
lines arranged evenly along the 300-mm axis (ie, every 37.5 mm). A
central region was chosen to permit quantification partially within the
medial portion of the DH innervated by the tibial nerve (ie, innervating
the centre of the plantar surface of the hind paw), and partially within
innervation territory of the common peroneal nerve (innervating the
centre of the dorsal surface of the hind paw),15,52 as neonatal
injection of CFA induced inflammation of the entire hind paw. The
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mean fluorescence intensity of each line was then calculated,
providing a profile of fluorescence intensity vs depth from the outer
surface of the DH for each target (referred to as the fluorescence
intensity profile). Mean fluorescence intensity profiles from 6 to 8
sections per animal were calculated.
2.6. Statistical analysis
Data are presented as mean 6 SEM, with n 5 1 defined as a
single animal. Data were tested for normality (Shapiro–Wilk tests)
and analysed with parametric or nonparametric statistical tests
where appropriate, with P , 0.05 considered statistically signifi-
cant. Data were analysed using Mann–Whitney U test, 2-way, or
repeated-measures (RMs) 2- or 3-way analysis of variance
(ANOVA), with Bonferroni post hoc tests where appropriate.
Hyperalgesic priming was considered to have occurred after
statistically significant decreases in mechanical threshold from
baseline 4 hours post-PGE2 injection. All statistical analyses were
performed using GraphPad Prism 8.1.
3. Results
3.1. Neonatal complete Freund’s adjuvant-induced
inflammation has no effect on adult inflammation-induced
mechanical hypersensitivity in male or female rats
Inflammation was induced inmale and female neonatal rats (aged
P1) through intraplantar injection of CFA (10 mL) or sham injection
(saline) under anaesthesia. Complete Freund’s adjuvant induced
substantial swelling and erythema of the entire hind paw,
extending to the ankle, which resolved within 7 days and was
not present in sham groups. At P60, there was no significant
difference in mechanical hind paw withdrawal thresholds
between rats receiving CFA or sham injection (Fig. 1A; Mann–
Whitney test, U 5 176, P 5 0.09; n 5 24 and 20 for CFA and
sham, respectively).
To investigate the potential effects of neonatal inflammation on
adult responses to reinjury, rats received an injection of 1%
l-carrageenan (5 mL; carra) into the centre of the plantar surface
of the hind paw. Carrageenan induced a significant decrease in
mechanical threshold when examined 1, 4, and 24 hours after
injection in both neonatal CFA- and saline-treated groups, and
thresholds returned to baseline within 1 week (Fig. 1B; 3-way RM
ANOVA with Bonferroni posttests; Time x Adult treatment in-
teraction, F4,1605 9.174;P, 0.001; n5 10–12). Neonatal CFAhad
no impact on adult responses to carrageenan at any timepoint (Time
3Neonatal treatment3Adult treatment interaction, F4,1605 0.477;
P5 0.752).
We then tested for potential sex differences in the effects of
neonatal CFA-induced inflammation on adult responses to
carrageenan-induced inflammation (Fig. 2). Carrageenan-
induced decreases inmechanical thresholds frombaseline lasted
significantly longer in female vs male rats (Fig. 2A; 3-way RM
ANOVA with Bonferroni posttests vs baseline; Time 3 Sex
interaction, F4,72 5 2.56; P 5 0.046; n 5 4–6). Female rats also
demonstrated a significantly lower area-under-curve of mechan-
ical threshold over time (Fig. 2B; 2-way ANOVA; Sex F1,18 5
5.005, P5 0.038). Neonatal treatment with CFA had no effect on
carrageenan-induced changes in mechanical threshold in either
male or female rats (Fig. 2A: 3-way RMANOVA; Time3Neonatal
treatment3 Sex interaction F4,725 0.399; P5 0.808; Fig. 2B: 2-
way ANOVA;Neonatal treatment3Sex interaction F1,185 0.840,
P 5 0.372).
3.2. Neonatal complete Freund’s adjuvant-induced
inflammation does not alter the development of
hyperalgesic priming
One week after intraplantar injection of carrageenan or saline
(animals now aged P67), the development of hyperalgesic priming
was examined through an intraplantar injection of PGE2 (1mg in 5mL
saline) or saline; decreased mechanical thresholds that were
maintained for at least 4 hours postinjection were deemed to be
indicative of hyperalgesic priming.2 PGE2 injection resulted in a
significant decrease in mechanical thresholds over time (Fig. 3; 2-
way RM ANOVA; Time 3 Treatment interaction F8,76 5 3.68, P 5
0.0011; n 5 5–6). Pre-PGE2 injection, there were no significant
differences in mechanical threshold between groups (Fig. 3; mean
mechanical threshold 5 23.5 6 0.77 g; Bonferroni posttests
between groups, P . 0.85 for all comparisons). One hour post-
PGE2 or saline injection, rats in all 4 treatment groups that received
PGE2 displayed a significant decrease in mechanical threshold from
baseline (neonatal/P60/P67 treatments: CFA/carra/PGE2; sham/
Figure 1. Neonatal CFA-induced inflammation does not alter adult mechanical thresholds or responses to repeat inflammation. (A) Intraplantar CFA (10 mL) at P1
did not alter mechanical paw withdrawal thresholds in adult (P60) rats (Mann–Whitney test; P 5 0.09; n 5 20 and 24 for sham and CFA, respectively). (B)
Carrageenan (5 mL; carra) in adult rats induced a significant decrease in PWT lasting at least 24 hours (3-way RM ANOVA; Time x Adult treatment interaction P,
0.001; Bonferroni posttests vs sham/saline, *P , 0.05; **P , 0.01; ***P , 0.001; n 5 10–12); however, neonatal CFA had no impact on adult responses to
carrageenan at any time point (Time 3 Neonatal treatment 3 Adult treatment interaction P 5 0.752). CFA, complete Freund’s adjuvant.
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carra/PGE2; CFA/saline/PGE2; sham/saline/PGE2), whereas those
injected with saline did not. At 4 hours, only those groups that
previously received carrageenan still exhibited reduced mechanical
thresholds (Fig. 3; Bonferroni posttests compared to baseline; P5
0.0011; n 5 5–6). Saline injection induced no alteration in
mechanical threshold from baseline.
Neonatal CFA did not alter adult primed responses to PGE2 at
any time point (Bonferroni posttests between groups at 1 and 4
hours postinjection; CFA/carra/PGE2 vs sham/carra/PGE2, P .
0.99; n5 5–6) nor did neonatal CFA induce hyperalgesic priming
(CFA/saline/PGE2 vs sham/saline/PGE2, P . 0.99; n 5 5–6).
3.3. Complete Freund’s adjuvant on P1 or P10 does not alter
broad distributions of CGRP and IB41 primary afferent
terminals in the adult spinal dorsal horn
The influence of intraplantar injection ofCFAat P1 (during the “critical
period” of long-term consequences of neonatal injury) and P10 (after
this critical period) on adult distributions of nonpeptidergic (IB41)
nociceptor innervation within the DH was examined by measuring
isolectin B4 (IB4) binding-associated fluorescence intensity along a
path through the DH, perpendicular to and originating at the exterior
of the SC (fluorescence intensity profile). IB4 binding was
concentrated to a band within the superficial laminae of the DH,
approximately 30 to 120 mm from the exterior (Figs. 4A and D).
There were no differences in fluorescence intensity profile of IB4
binding within the DH ipsilateral to neonatal injury between groups
(Fig. 4E; intraplantar CFA or sham injection at P1 or P10; 3-way RM
ANOVA;Depth3Age at injury3 Injury interaction: F8,725 0.51;P5
0.84; n 5 3–4). Peptidergic (CGRP1) nociceptor innervation was
also examined; CGRP immunostaining was restricted to a narrow
band of high-intensity staining in the superficial DH, approximately
corresponding with laminae I and IIo (Figs. 5A and D). As with IB4
staining, no differences were found in the fluorescence intensity
profiles of DH CGRP staining between groups (Fig. 5E; 3-way RM
ANOVA; F8, 72 5 1.23, P5 0.30, n5 3–4).
4. Discussion
Pain during the neonatal period has a substantial impact on the
postnatal development of nociceptive circuitry, leading to persistent
global increases in acute mechanical and thermal thresholds
(hypoalgesia) and increased responses to reinjury at the site of initial
inflammation (hyperalgesia).53 Previous studies investigating mech-
anismsdriving these changes have identified alterations in spinal and
supraspinal nociceptive circuitry. Within the spinal cord, increased
activation of microglia,6 facilitated long-term potentiation of DH
interneurons,32 and increased PAF input, together with decreased
inhibitory input, onto lamina I projection neurons,34 are among the
mechanisms that are proposed to lead to increased hyperalgesia in
adulthood. Global hypoalgesia is thought to arise from decreased
rostral ventromedialmedulla (RVM)-mediated descending facilitation
and a predominance of inhibition of DH nociceptive processing
developing after neonatal injury,54 increased opioid tone within the
RVM and periaqueductal gray,31 and a decrease in the intrinsic
excitability of lamina II interneurons.33
Although studies have shown that early-life colonic inflamma-
tion increases visceral afferent expression TRPA114 and Nav1.8
and decreases A-type K1 currents,43,44 few studies have
investigated changes in primary afferent function after cutaneous
inflammation in the neonate. Here, we investigated whether
hyperalgesic priming, PKCe-mediated neuroplasticity of IB41
afferent responses to repeat inflammation,2 may contribute to
exacerbated responses to reinjury in adulthood. We have shown
that neonatal CFA-induced inflammation does not induce
hyperalgesic priming of primary afferent nociceptors or alter its
development in adult life. In parallel, distributions of peptidergic
and nonpeptidergic C-fibre terminals in the adult DH were
unaltered after neonatal CFA-induced inflammation.
4.1. Neonatal complete Freund’s adjuvant-induced
inflammation had no effect on adult mechanical thresholds
before or after adult inflammatory injury
Complete Freund’s adjuvant-induced inflammation at P1 had no
effect on baseline mechanical thresholds in adult life. Our findings
correlate with several previous studies showing that hind paw
CFA or carrageenan injection during the neonatal period did not
result in changes in mechanical or thermal thresholds in adult
life.36,48,55 These collective results are in contrast to the long-term
effects of other models of neonatal injury, including hind paw
surgical incision,6,54,56 which result in global mechanical and
thermal hypoalgesia in adult life. We also found that neonatal CFA
had no effect on inflammation-induced changes in mechanical
Figure 2. Sex differences in mechanical hypersensitivity after intraplantar carrageenan injection in adulthood after neonatal CFA-induced inflammation. (A)
Carrageenan (carra; 1%, 5mL) induced a significant decrease inmechanical thresholds frombaseline in all groups, and this was different betweenmale and female
rats (3-way ANOVA; significant Time and Time 3 Sex interactions; P 5 , 0.001 and 0.046, respectively; n 5 4–6). However, neonatal treatment (CFA or sham
injection) had no effect on adult responses to carrageenan (Time3Neonatal treatment3Sex interaction,P5 0.808) (B) Area-under-curve analysis of alterations in
mechanical threshold also showed a significant difference between male and female rats, but no effect of neonatal treatment (2-way ANOVA; Sex P5 0.038 (*);
Sex 3 Neonatal treatment P 5 0.371). ANOVA, analysis of variance; CFA, complete Freund’s adjuvant.
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threshold in adulthood. This correlates with Walker et al.55 who
found no alterations in adult thresholds after neonatal CFA or
carrageenan, but is in contrast to several previous studies, in
which neonatal hind paw CFA,36,48 carrageenan,46 surgical
incision,6,56 or repetitive pin-prick11 caused a greater magnitude
of decrease in mechanical threshold and thermal withdrawal
latencies upon reinjury compared to control animals that did not
experience neonatal injury.
These inconsistencies between this study and previous work
may be explained by the extent of painful experience occurring
during the neonatal period. Several studies have shown that
administration of CFA or carrageenan at P1-3 does not induce
Figure 3. Neonatal CFA-induced inflammation has no effect on the development of hyperalgesic priming in adult rats. Mechanical PWT after intraplantar injection
of PGE2 (1 mg in 5 mL saline) or saline, 7 days after carrageenan or saline injection and after neonatal CFA or saline administration. One hour after injection, all
groups receiving PGE2 experienced a significant decrease in PWT, whilst those receiving saline did not; at 4 hours, only those groups previously receiving
carrageenan maintained decreased PWTs (2-way RM ANOVA with Bonferroni posttests vs baselines; 1P , 0.05; 11P , 0.01; 111P , 0.001; n 5 5–6).
Neonatal CFA had no effect on adult responses to PGE2 (Bonferroni posttests, P . 0.05). ANOVA, analysis of variance; CFA, complete Freund’s adjuvant.
Figure 4. Intraplantar CFAatP1 or P10has no effect on adult nonpeptidergic primary afferent fibre terminal staining in the dorsal horn (DH). (A–D) Representative imagesof
IB4 binding in the ipsilateral DH at P67 after intraplantar CFA or saline at P1 or 10. Scale bars5 50 mm. Quantification method is shown in (A): a 2003 300-mmgrid was
placed as shown across the dorsal horn. The mean fluorescence intensity across each of the 9 horizontal lines was then calculated to provide a profile of fluorescence
intensity vs depth from dorsal surface of the dorsal horn gray matter. (E) Fluorescence intensity profiles of IB4 binding in the ipsilateral DH. No significant differences were
observed between groups (3-way RM ANOVA; P5 0. 84; n5 3–4). ANOVA, analysis of variance; CFA, complete Freund’s adjuvant; RM, repeated-measures.
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acute decreases in mechanical threshold despite the presence of
inflammation.3,48,55 By contrast, others have shown that surgical
hind paw incision54,56 and injection of carrageenan46 induces
short-lived mechanical hypersensitivity. Perioperative sciatic
nerve block during the neonatal incision injury prevents the
development of long-term somatosensory alterations after neo-
natal hind paw incision,54,56 suggesting that nociceptive drive is
required to develop long-term alterations in somatosensation,
and the presence of peripheral inflammation alone may not be
sufficient to generate this effect.
Previous studies showing neonatal CFA-induced vulnerability
to reinjury in adulthood24,36,48 used a larger dose (25 mL dose of
CFA diluted 1:1 in saline) than used in this study (10 mL). 25 mL of
CFA administered to neonatal rats generates chronic inflamma-
tory changes persisting well into adulthood,36,55 accounting for
long-term vulnerability to inflammation despite a lack of acute
hypersensitivity during the initial injury.
4.2. Sex differences in inflammation-induced
mechanical hypersensitivity
In this study, carrageenan-induced decreases in mechanical
withdrawal thresholds were slower to resolve in females than in
males. This correlates with other reports of increased severity or
duration of mechanical or heat hypersensitivity after intraplantar
carrageenan in female rodents,13,35 although this effect was not
shown by Joseph et al.26 who found that duration and severity
was increased in male compared to female rats. Females have
been shown to produce a larger proinflammatory immune
response to tissue damage than males, potentially resulting in
the accumulation of increased levels of proinflammatory cyto-
kines that result in peripheral sensitization.47
Reports of sex differences in the effects of neonatal injury on
somatosensation in later life are mixed. Neonatal carrageenan
injection was reported to induce a greater degree of global
hypoalgesia and enhanced hyperalgesia upon reinjury in adult
female rats than in males.31 By contrast, neonatal hind paw
incision enhanced hyperalgesia upon reinjury to a similar extent in
male and female rats, although this was dependent on microglial
function in males but not in females.39 Another study reported
that neonatal hind paw incision induced mechanical and thermal
hypersensitivity in male, but not female, adolescent (P28–40)
mice.10 Here, neonatal treatment had no impact on the extent or
resolution of adult inflammation-induced mechanical hypersen-
sitivity in either sex.
4.3. Neonatal complete Freund’s adjuvant did not alter the
development of, or induce, hyperalgesic priming
This study showed that prior application of carrageenan in adults
generated a prolonged PGE2-mediated hyperalgesic response,
in agreement with previous demonstrations of type I (injury-
Figure 5. Intraplantar CFA at P1 or P10 has no effect on adult peptidergic primary afferent fibre terminal staining in the dorsal horn (DH). (A–D) Representative
images of CGRP immunostaining in the ipsilateral DH at P67 after intraplantar CFA or saline at P1 or 10. Scale bars5 50 mm. (E) Fluorescence intensity profiles of
CGRP staining in the ipsilateral DH. No significant differences were observed between groups (3-way RM ANOVA; P 5 0.30; n 5 3–4). ANOVA, analysis of
variance; CFA, complete Freund’s adjuvant; RM, repeated-measures.
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induced) hyperalgesic priming after hind paw carrageenan or CFA
injections in adulthood.2,9,26 However, neonatal CFA did not alter
the response to carrageenan, nor the development of hyper-
algesic priming (revealed after intraplantar injection of PGE2),
compared with rats that received saline in the neonatal period.
This finding is of interest because in adults, hyperalgesic priming
persists for several months after the initial injury.2,17,42 In addition,
development of priming in adults is not dependent on the
hyperalgesia accompanying the initial noxious insult,2 meaning
that a lack of hyperalgesia accompanying neonatal inflammation
would not be expected to be sufficient to explain the failure to
induce hyperalgesic priming in adulthood. This may suggest that
PKCe-mediated alterations in nociceptive processing differ
between neonates and adults. This could be due to a lack of
functional IB41 nociceptor innervation of the DH during the first
postnatal week,7 or differences in the acute inflammatory
process, or PKCe-mediated signalling pathways. Regardless of
mechanism, we speculate that previously observed long-term
effects of painful neonatal experience6,53,56 are unlikely to be
related to mechanisms involved in type I hyperalgesic priming.
However, PGE2 can induce hypersensitivity for at least 24 hours in
primed animals17,26; given that we did not examine the time-
course of resolution of PGE2-medated hypersensitivity, our data
cannot exclude the possibility that neonatal CFA may alter the
duration of primed responses to PGE2. Furthermore, our findings
do not preclude the possibility that other models of neonatal injury
that induce long-term vulnerability to reinjury (such as hind paw
incision6) may induce hyperalgesic priming or exacerbate the
development of priming in adulthood.
4.4. Early life complete Freund’s adjuvant does not alter
peptidergic and nonpeptidergic afferent termination in the
adult dorsal horn
Primary afferent termination patterns in the DH undergo sub-
stantial postnatal maturation; peptidergic C fibres are functional
from the late gestational stages and sparsely project to the DH
during this period, whereas IB4-binding C fibres are do not
terminate in the DH until P5 and noxious stimulus-mediated
activity is not present until P10.4,20 In addition, neonatal
inflammation increases CGRP expression and IB4 binding in
dorsal root ganglia neurons during this period of postnatal
maturation.8 Here, we have shown that hind paw CFA-induced
inflammation at P1 (during the “critical period” of long-term
consequences of neonatal injury) or P10 (after the critical period)
46 does not alter the intensity or broad distribution of CGRP-
associated immunofluorescence or IB4 binding in the adult DH.
Regardless of treatment, CGRP1, peptidergic immunostaining
was visible in the superficial DH, approximately in laminae I and II,
whilst IB4 staining was present deeper in lamina II to III, reflecting
normal adult patterns.51
Previous studies demonstrating alterations in PAF innervation
of theDHafter neonatal injury identified rostrocaudal expansion of
nerve terminals48 and increases in lamina III to V CGRP
immunoreactivity37; however, these studies used a dose of CFA
that induces chronic inflammation lasting well into adulthood,55
which does not reflect neurodevelopmental plasticity or resemble
human neonatal experience. Our findings do not exclude the
possibility of PAF synaptic reorganization from contributing to
long-term alterations in somatosensation; despite bulk patterns
of C-fibre termination not changing after neonatal CFA-induced
inflammation, it is possible that the integration of PAF connectivity
with specific populations of second order neurons may be
altered, as has been demonstrated for NK1-expressing pro-
jection neurons.34
4.5. Conclusions and implications for future directions
We have shown that CFA-induced inflammation during the
neonatal period does not induce or alter the development of
hyperalgesic priming. Furthermore, we have shown that early-life
CFA-induced inflammation did not alter postnatal reorganization of
C-fibre input into the DH. These findings point towards other
potential mechanisms, which may include a contribution of the
descending control pathways. The RVM undergoes significant
postnatal development,22,28,29 and neonatal injury significantly
alters adult descending pathways from the RVM.54 Although
selective ablation of serotonergic input to the DH (ie, arising from
theRVM16,18) attenuates the initial, acute phase of PGE2-mediated
hyperalgesia in adult rodents, it does not influence the chronic
phase, demonstrating that this pathway does not contribute to the
development of hyperalgesic priming.27 By contrast, ablation of
dopaminergic projection neurons arising from the hypothalamic
A11 nucleus resulted in a failure of the development of hyperalgesic
priming in adulthood.38 To date, the postnatal development of
hypothalamic descending control of nociception has yet to be
characterised, and therefore whether the lack of hyperalgesic
priming after neonatal CFA-induced inflammation herein arises due
to functional different hypothalamic descending control pathways
in neonates, compared to adults, remains to be explored. Future
studies examining synaptic integration of PAFs into DH circuitry
and supraspinal control of spinal nociceptive processing may
further elucidate themechanisms underpinning life-long alterations
in somatosensation after painful neonatal experience.
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a or b eliminates sex differences in mechanical pain threshold in normal
and inflamed mice. PAIN 2009;143:37–40.
[36] Lim EJ, Back SK, Kim MA, Li C, Lee J, Jeong KY, Na HS. Long-lasting
neonatal inflammation enhances pain responses to subsequent
inflammation, but not peripheral nerve injury in adult rats. Int J Dev
Neurosci 2009;27:215–22.
[37] Ling QD, Chien CC, Wen YR, Fu WM, Sun WZ. The pattern and
distribution of calcitonin gene-related peptide (CGRP) terminals in the rat
dorsal following neonatal peripheral inflammation. Neuroreport 2003;14:
1919–21.
[38] Megat S, Shiers S, Moy JK, Barragan-Iglesias P, Pradhan G, Seal RP,
Dussor G, Price TJ. A critical role for dopamine D5 receptors in pain
chronicity in male mice. J Neurosci 2018;38:379–97.
[39] Moriarty O, Tu YS, Sengar AS, Salter MW, Beggs S, Walker SM. Priming
of adult incision response by early-life injury: neonatal microglial inhibition
has persistent but sexually dimorphic effects in adult rats. J Neurosci
2019;39:3081–93.
[40] Moy JK, Kuhn JL, Szabo-Pardi TA, Pradhan G, Price TJ. eIF4E
phosphorylation regulates ongoing pain, independently of inflammation,
and hyperalgesic priming in the mouse CFA model. Neurobiol Pain 2018;
4:45–50.
[41] Parada CA, Reichling DB, Levine JD. Chronic hyperalgesic priming in the
rat involves a novel interaction between cAMP and PKCepsilon second
messenger pathways. PAIN 2005;113:185–90.
[42] Parada CA, Yeh JJ, Reichling DB, Levine JD. Transient attenuation of
protein kinase Ce can terminate a chronic hyperalgesic state in the rat.
Neuroscience 2003;120:219–26.
[43] Qian AH, Liu XQ, Yao WY, Wang HY, Sun J, Zhou L, Yuan YZ. Voltage-
gated potassium channels in IB4-positive colonic sensory neurons
mediate visceral hypersensitivity in the rat. Am J Gastroenterol 2009;
104:2014–27.
[44] Qu R, Tao J, Wang Y, Zhou Y, Wu G, Xiao Y, Hu C, Jiang X, Xu G.
Neonatal colonic inflammation sensitizes voltage-gated Na1 channels
via upregulation of cystathionine b-synthetase expression in rat primary
sensory neurons. Am J Physiol Liver Physiol 2013;304:G763–72.
[45] Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic
pain. Trends Neurosci 2009;32:611–8.
[46] Ren K, Anseloni V, Zou SP, Wade EB, Novikova SI, Ennis M, Traub RJ,
Gold MS, Dubner R, Lidow MS. Characterization of basal and re-
inflammation-associated long-term alteration in pain responsivity
following short-lasting neonatal local inflamatory insult. PAIN 2004;110:
588–96.
[47] Rosen S, Ham B, Mogil JS. Sex differences in neuroimmunity and pain.
J Neurosci Res 2017;95:500–8.
[48] Ruda MA, Ling QD, Hohmann AG, Peng YB, Tachibana T. Altered
nociceptive neuronal circuits after neonatal peripheral inflammation.
Science 2000;289:628–31.
[49] Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch
T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ,
Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source
platform for biological-image analysis. Nat Methods 2012;9:676–82.
[50] Schmelzle-Lubiecki BM, Campbell KAA, Howard RH, Franck L,
Fitzgerald M. Long-term consequences of early infant injury and trauma
upon somatosensory processing. Eur J Pain 2007;11:799–809.
[51] Snider WD, McMahon SB. Tackling pain at the source: new ideas about
nociceptors. Neuron 1998;20:629–32.
[52] Swett JE, Woolf CJ. The somatotopic organization of primary afferent
terminals in the superficial laminae of the dorsal horn of the rat spinal cord.
J Comp Neurol 1985;231:66–77.
[53] Walker SM, Beggs S, Baccei ML. Persistent changes in peripheral and
spinal nociceptive processing after early tissue injury. Exp Neurol 2016;
275:253–60.
[54] Walker SM, Fitzgerald M, Hathway GJ. Surgical injury in the neonatal rat
alters the adult pattern of descending modulation from the rostroventral
medulla. Anesthesiology 2015;122:1391–400.
[55] Walker SM, Meredith-Middleton J, Cooke-Yarborough C, Fitzgerald M.
Neonatal inflammation and primary afferent terminal plasticity in the rat
dorsal horn. PAIN 2003;105:185–95.
[56] Walker SM, Tochiki KK, Fitzgerald M. Hindpaw incision in early life
increases the hyperalgesic response to repeat surgical injury: critical
period and dependence on initial afferent activity. PAIN 2009;147:
99–106.
[57] Zhang YH, Wang XM, Ennis M. Effects of neonatal inflammation on
descending modulation from the rostroventromedial medulla. Brain Res
Bull 2010;83:16–22.
8 A.H. Cooper et al.·5 (2020) e872 PAIN Reports®
